
Preclinical testing at The Ohio State University found Telomir-Zn inhibited growth of canine and human osteosarcoma cell lines, prompting the company to explore a possible in-vivo study in dogs with naturally occurring tumors.
Roll over the circles to read whether you share the characteristics of a Doczilla.
Illustration by Gail Armstrong.
Share your hospital design horror stories. Every veterinarian who's in the midst of building a new facility has a Doczilla moment—or two. Tell us yours by e-mailing us at





